BCA-225 Breast carcinoma associated glycoprotein 225, or BCA-225, has been identified exclusively in breast cancers and certain adenocarcinomas, as one of the biomarkers. Unlike other identified proteins, monoclonal antibodies for BCA-225 (clonesCU18, CU26, and CU46) show no cross reactivity with lactating mammary glands and with gastrointestinal malignancies. This restricted distribution and frequency in breast carcinomas gives BCA-225 considerable clinical significanc in diagnosis and treatment of breast and other adenocarcinomas.
Intended Use: IVD
Antibody Type: Monoclonal
Clone: Cu-18
Source: Mouse
Tissue Type/Cancer Type: Breast Cancer